---
title: "Wellgistics Health, Inc. 1Q 2026: Revenue $1.56M, EPS ($0.07) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286961026.md"
description: "Wellgistics Health, Inc. reported Q1 2026 revenue of $1.56M, down 85.6% from $10.86M a year ago, with a net loss of $7.74M, an improvement from a $32.43M loss in the previous year. The decline in revenue was attributed to reduced distribution activity and liquidity issues, while pharmacy retail sales increased. The company completed acquisitions to enhance its healthcare ecosystem and is investing in sales and marketing to boost brand awareness and customer acquisition."
datetime: "2026-05-19T20:11:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286961026.md)
  - [en](https://longbridge.com/en/news/286961026.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286961026.md)
---

# Wellgistics Health, Inc. 1Q 2026: Revenue $1.56M, EPS ($0.07) — 10-Q Summary

Wellgistics Health, Inc. reported first-quarter 2026 results with revenue of $1.56M and a net loss of $7.74M (loss per diluted share $0.07), versus $10.86M in revenue and a net loss of $32.43M (loss per share $0.62) in the year‑ago quarter.

**Financial Highlights**

-   Revenue was $1.56M for Q1 2026, down from $10.86M in the year‑ago quarter; YoY change (85.6%).
-   Net income (loss) was a loss of $7.74M for Q1 2026, improved from a loss of $32.43M in the year‑ago quarter; YoY change (76.1%).
-   Diluted EPS was a loss of $0.07 for Q1 2026, compared with a loss of $0.62 in the year‑ago quarter.

**Business Highlights**

-   Net revenues fell roughly 86% year over year, driven by a sharp decline in distribution activity and constrained procurement due to liquidity issues.
-   The company saw a channel mix shift: distribution revenue collapsed while pharmacy retail sales grew materially, increasing pharmacy’s contribution and improving gross margin.
-   Completed prior acquisitions — Wellgistics LLC, Wellgistics Tech & Hub (DelivMeds), and Wellgistics Pharmacy — to form an integrated healthcare ecosystem.
-   DelivMeds tech hub is scaling SaaS, hub and clinical concierge offerings targeting specialty-lite markets and data monetization opportunities.
-   Management increased sales and marketing investment to drive brand awareness, customer acquisition and expansion of pharmacy operations and manufacturer relationships.

Original SEC Filing: Wellgistics Health, Inc. \[ WGRX \] - 10-Q - May. 19, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [WGRX.US](https://longbridge.com/en/quote/WGRX.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XPH.US](https://longbridge.com/en/quote/XPH.US.md)
- [PPH.US](https://longbridge.com/en/quote/PPH.US.md)
- [PJP.US](https://longbridge.com/en/quote/PJP.US.md)

## Related News & Research

- [Wellgistics Health withdraws preliminary proxy as it evaluates strategic alternatives](https://longbridge.com/en/news/286762404.md)
- [Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services  | WGRX Stock News](https://longbridge.com/en/news/286266971.md)
- [AleAnna, Inc. Reports First Quarter 2026 Results | ANNA Stock News](https://longbridge.com/en/news/286463118.md)
- [Stocks in Play: WELL Health Technologies Corp.](https://longbridge.com/en/news/286934552.md)
- [Patrick Industries, Inc. Declares Quarterly Cash Dividend | PATK Stock News](https://longbridge.com/en/news/286565699.md)